Oragenics, Inc.
OGEN
$0.59
$0.035.45%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.29M | -3.07M | -2.27M | -2.22M | -3.35M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 578.60K | 192.90K | -- |
| Total Other Non-Cash Items | 738.00K | 6.00K | 6.60K | -68.80K | 57.70K |
| Change in Net Operating Assets | -1.29M | 76.00K | 372.50K | -19.20K | 1.27M |
| Cash from Operations | -2.84M | -2.98M | -1.31M | -2.11M | -2.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -167.50K | 394.80K | 0.00 | 2.23M | -- |
| Total Debt Repaid | 0.00 | -3.00M | -133.00K | -195.60K | -262.80K |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 2.64M | 2.00K |
| Repurchase of Common Stock | -1.10K | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 15.02M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -168.60K | 12.41M | -133.00K | 4.67M | -260.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.00M | 9.43M | -1.45M | 2.56M | -2.28M |